BCDA's logo.
Ticker Symbol: BCDA

BioCardia Inc.

$2.37 - 17-07-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0000925741

Company Profile

we are a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. biocardia is developing proprietary comprehensive biotherapeutic solutions for cardiovascular disease in its cardiamp™ and cardiallo™ therapies. clinical results supporting both therapeutic programs are compelling and build upon the most rigorous data in the field to date with intramyocardial delivery of marrow-derived cells. these programs are enabled by the company's helix™ transendocardial delivery systems and morph® vascular access products, which are partnered to enable other promising biotherapeutic programs.

Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3842
Address: 125 Shoreway Rd Ste B
CEO: Peter Altman
  • Biotechnology
  • Health Technology
  • Manufacturing
  • Surgical and Medical Instrument Manufacturing


Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $0.38
Change: $0.00 ( -0.38%)
Days Range: $0.38 - $0.40
Beta: 0.12
52wk. High: $2.92
52wk. Low: $0.36
Ytd. Change -81.75%
50 Day Moving Average: $0.43
200 Day Moving Average: $1.46
Shares Outstanding: 21619432


Market Cap: 842.1M
PE Ratio: -
EPS (TTM): 0


Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A